West Pharmaceuticals

West Pharmaceutical Services (NYSE:WST) announced today that it launched its NovaPure 0.5 mL plunger for ISO glass syringes. Exton, Pennsylvania-based West designed the syringes to meet the performance and quality requirements for ophthalmic drug applications. The plunger is West’s newest ready-to-use elastomer component within the NovaPure portfolio. This includes the existing 1 mL and 1-3…

West Pharmaceutical Services (NYSE:WST) announced the opening of a new facility for contract services in Dublin, Ireland. IDA Ireland, the foreign direct investment arm for the Irish government, shared the announcement of the Damastown site’s opening. The 165,000-square-foot expansion enhances West’s contract services. It helps meet the growing demand for high-volume treatments, including for diabetes…

AbbVie (NYSE: ABBV) recently announced that it has acquired a West Pharmaceutical Services (NYSE: WST) plant in Tempe, Arizona. North Chicago, Illinois–based AbbVie said on Jan. 12 that it plans to hire roughly 200 employees at the site and invest more than $175 million to acquire, modernize, and fully integrate the facility into its manufacturing…

West Pharmaceutical Services announced that it completed an $80 million capacity expansion at a contract manufacturing site in Michigan. The investment extends production and accessibility for patient-centric diabetes and obesity products at the Grand Rapids facility. It comes in response to increasing demand from West’s customers for device and drug delivery manufacturing solutions to support…

West Pharmaceutical Services (NYSE:WST) shares dipped slightly despite third-quarter results that topped the consensus forecast. The Exton, Pa.-based company posted profits of $82.3 million, or $1.09 per share, on sales of $548 million for the three months ended Sept. 30, 2020, for a 46.2% bottom-line gain on sales growth of 0.3%. Get the full story at…